|
|
|
|
|
|
|
|
|
|
open access
This review will give a glimpse on the genomic advances in OC. Particular interest will be focused on the translating insight of these genomic alterations into clinical and pathological practice[Table 1].
A combination of target therapy, epigenetic therapy and conventional
therapy, will holds great promise for the treatment of OCs in the future.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.